Friday, August 14, 2026

Baltimore man sentenced to five years for fentanyl distribution in West Virginia

A Baltimore man has been sentenced to five years in federal prison for distributing fentanyl in West Virginia. The case
X / Twitter
LinkedIn
Print

A Baltimore, Maryland, man was sentenced on July 16 to five years in federal prison for selling fentanyl in Harrison County, West Virginia, according to U.S. Attorney Matthew L. Harvey.

Paul Samuel Williams, age 27 and also known as “G,” received a sentence of 60 months for distributing 40 grams or more of fentanyl. Prosecutors said Williams sold 51 grams of fentanyl for $3,500 in the parking lot of a business located in Bridgeport, West Virginia. Authorities noted that Williams has a criminal history with multiple drug convictions.

After completing his prison term, Williams will be subject to three years of supervised release.

The case was prosecuted by Assistant U.S. Attorney Will Rhee and investigated by the Greater Harrison Drug Task Force, which is funded through the High Intensity Drug Trafficking Areas initiative.

Fentanyl has been designated as a weapon of mass destruction by President Donald Trump due to its extreme lethality and threat to public safety even in small amounts. This prosecution falls under Operation Take Back America, an initiative aiming at eliminating cartels and transnational criminal organizations while protecting communities from violent crime and illegal immigration.

Chief U.S. District Judge Thomas S. Kleeh presided over the sentencing.

Filed Under

Share This Story

X / Twitter
LinkedIn
Email
Print

Advertisement

300 × 250

Related

DEA Details Ongoing Operations Against CJNG Cartel

Daily Dispatch

The morning briefing on federal government — delivered to your inbox before 7 AM.

Advertisement

300 × 120

More from Defense

USPTO Study Finds IP-Intensive Industries Account for 44% of US GDP

The U.S. Patent and Trademark Office released a report finding that IP-intensive industries account for 44% of U.S. gross domestic product and employ approximately one-third of the American workforce on...

EPA Takes Next Step in Accelerated Review of Fluoride in Drinking Water

The Environmental Protection Agency released its Protocol for Developing the Fluoride Human Health Toxicity Assessment, marking the next step in an accelerated review of public health risks linked to fluoride...

FDA Approves First Drug to Treat Full Range of Narcolepsy Symptoms

The Food and Drug Administration approved the first drug to address the complete symptom profile of narcolepsy type 1, covering both excessive daytime sleepiness and cataplexy, on Aug. 5. Prior...